State Of Wisconsin Investment Board Iveric Bio, Inc. Transaction History

State Of Wisconsin Investment Board

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$26.24 - $39.63 $134,742 - $203,500	-5,135 Reduced 4.89%	99,975 $3.93 Million
Q1 2023 May 15, 2023	SELL	$18.67 - $24.56 $171,726 - $225,902	-9,198 Reduced 8.05%	105,110 $2.56 Million
Q4 2022 Feb 14, 2023	BUY	$17.24 - $23.95 $563,558 - $782,901	32,689 Added 40.05%	114,308 $2.45 Million
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $38,916 - $76,962	-4,140 Reduced 4.83%	81,619 $1.46 Million
Q2 2022 Aug 15, 2022	SELL	$9.12 - $18.9 $614,149 - $1.27 Million	-67,341 Reduced 43.98%	85,759 $825,000

Q1 2022 May 13, 2022	SELL	$12.15 - $16.83 $264,870 - $366,893	-21,800 Reduced 12.46%	153,100 $2.58 Million
Q4 2021 Feb 11, 2022	BUY	$13.83 - $18.78 $611,286 - $830,076	44,200 Added 33.82%	174,900 $2.92 Million
Q3 2021 Nov 12, 2021	BUY	$7.07 - $17.5 $123,725 - $306,250	17,500 Added 15.46%	130,700 $2.12 Million
Q4 2020 Feb 03, 2021	BUY	$5.65 - $7.66 $227,695 - $308,698	40,300 Added 55.28%	113,200 $782,000
Q3 2020 Nov 16, 2020	BUY	$4.01 - $6.29 $292,329 - $458,541	72,900 New	72,900 $411,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.